FindTrial
Sign In

The effect of inflammatory bowel disease and its therapeutic drugs on aortic calcification

Effect of inflammatory bowel disease and its therapeutic drugs on aortic calcification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064526
Enrollment
Unknown
Registered
2022-10-11
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic calcification in patients with inflammatory bowel disease

Interventions

Group 1 :
Group 2:

Sponsors

Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. 15 to 74 years old; 2. Clinically diagnosed IBD; 3. Have chest/abdomen CT examination before and after treatment;

Exclusion criteria

Exclusion criteria: 1. There was a history of cardiovascular or cerebrovascular diseases before the diagnosis of IBD; 2. Combined with rheumatic immune diseases; 3. Combined with other diseases that require long-term use of hormones (> 6 months); 4. Patients with chronic kidney disease or long-term regular hemodialysis.

Design outcomes

Primary

MeasureTime frame
CT aortic calcification score;Prevalence of aortic calcification in patients with IBD;—

Countries

China

Contacts

Public ContactLei Juan

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

leijuan@mail.sysu.edu.cn+86 13650894373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026